Asian home health care market is expected to reach USD 62.32 Billion by 2020 from USD 39.07 Billion in 2015, at a CAGR of 9.8% from 2015 to 2020.

Asian home health care market is further segmented into rehabilitation therapy services, infusion therapy services, unskilled care services, respiratory care services, pregnancy care services, skilled nursing care services, and hospice and palliative care services. The infusion therapy services segment is expected to grow at the highest CAGR during the forecast period.

Download FREE Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=227642968

The telehealth market is further segmented into telehealth monitoring devices, telehealth services, and telehealth software solutions. In 2015, the telehealth monitoring devices segment is estimated to account for the largest share of the Asian telehealth market as these devices offer easy connectivity and are easy to use.

By Region

While Japan is estimated to dominate the market in 2015, China is expected to grow at the highest CAGR during the forecast period. Increasing adoption of new technologies, rapidly growing geriatric population, increasing incidences of chronic diseases, growing disposable incomes, rising demand for affordable healthcare alternatives, and expansion of major players in this region will drive the growth of the Asian home health care market in China.

The key players

Asian home health care market include Philips Healthcare (Netherlands), Linde Group (Germany), Abbott Laboratories (U.S.), Johnson & Johnson (U.S.), A&D Company Limited (Japan), Fresenius SE & Co. KGaA (Germany), Omron Corporation (Japan), Roche Holdings AG (Switzerland), Portea Medical Pvt. Ltd. (India), Teijin Limited (Japan), and GE Healthcare (U.K.).

To Know More @ https://www.marketsandmarkets.com/Market-Reports/asian-home-health-care-market-227642968.html